Table 1.
Characteristics of studies assessing the public health and/or economic impact of dairy products for fracture prevention
First author | Country | Publication year | Method | Outcomes | Intervention | Intervention effects |
---|---|---|---|---|---|---|
1. Lotters | Netherlands, France, Sweden | 2013 | Model | PH: costs, number of hip fractures, DALY | Increasing dairy foods consumption | Not reported |
2. Hiligsmann | Belgium | 2015 | Markov microsimulation model | CE: cost per QALY gained | Calcium and vitamin D supplementation (compared with no treatment) | 18% hip; 13% VFX; 20% other |
3. Ethgen | Belgium | 2015 | Population-based model (using Markov microsimulation model) | PH: fractures avoided, life years gained; CE: cost per fracture avoided; cost per life year | Daily administration of one, two, or three portions of a yogurt fortified with vitamin D | 18% hip; 13% VFX; 20% other |
4. Ethgen | Belgium | 2016 | Markov microsimulation model | CE: cost per QALY gained | Daily administration of one, two, or three portions of a yogurt fortified with vitamin D | 18% hip; 13% VFX; 20% other |
5. Sandmann | Germany | 2016 | Spreadsheet-based model | PH: costs, fracture prevented; CE: benefit-cost ratio | Food-fortification programmes | 9% or 25% hip; 14% VFX; 11% other |
6. Hagen | Norway | 2016 | Markov model | CE: cost per QALY gained | Calcium and vitamin D supplementation (compared with no treatment) | 16% hip; 11% VFX; 15% other |
7. Hiligsmann | France | 2017 | Markov microsimulation model | PH: fractures prevented, QALY gained, life years gained; CE: cost per QALY gained | Recommended intake of vitamin D-fortified dairy products (2 products per day in base case) | 16% hip; 14% VFX; 11% other |
CE cost-effectiveness, DALY disability-adjusted life years, PH public health, QALY quality-adjusted life years, VFX vertebral fracture